201. Activation and suppression of renin-angiotensin system in human dendritic cells.
- Author
-
Lapteva N, Ide K, Nieda M, Ando Y, Hatta-Ohashi Y, Minami M, Dymshits G, Egawa K, Juji T, and Tokunaga K
- Subjects
- Angiotensin II pharmacology, Base Sequence, Captopril pharmacology, Cytokines metabolism, DNA Primers, Dendritic Cells metabolism, Enzyme-Linked Immunosorbent Assay, Gene Expression Profiling, Humans, Inflammation Mediators metabolism, Reverse Transcriptase Polymerase Chain Reaction, Renin-Angiotensin System
- Abstract
We previously identified the gene expression of renin-angiotensin system in human monocyte-derived dendritic cells (DCs). This study was conducted to examine the mechanisms by which angiotensin II and captopril, the inhibitor of the angiotensin-converting enzyme (ACE), affect human DCs. In DCs, lipopolysaccharide (LPS)-induced production of tumor necrosis factor-alpha (TNF-alpha), interleukin-(IL)-1alpha, IL-10, IL-12, and IL-18 was significantly inhibited by captopril. In contrast, angiotensin II treatment resulted in a significant increase in TNF-alpha and IL-6 protein biosynthesis by DCs. In addition, we have studied the global expression of 2400 genes in DCs from two donors. Here, we demonstrated the specific down-regulation of the ACE gene expression in captopril-treated DCs. Our finding indicates the possible activation of NF-kappaB through the up-regulation of expressions of MEFV gene (encoding PYRIN protein) and heterogeneous nuclear ribonucleoprotein R in DCs. This is the first study on the modulation of cytokine and gene expression by angiotensin II and captopril in DCs.
- Published
- 2002
- Full Text
- View/download PDF